Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study

Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study

<p>Abstract</p> <p>Background</p> <p>Although the validity and safety of antipsychotic polypharmacy remains unclear, it is commonplace in the treatment of schizophrenia. This study aimed to investigate the degree that antipsychotic polypharmacy contributed to metabolic...

Full description

Bibliographic Details
Main Authors: Okumura Yasuyuki, Oguchi Yoshiyo, Shida Hirokazu, Kobayashi Mihoko, Koshiishi Fumio, Miyata Ryouji, Fujii Yasuo, Shimizu Keiko, Misawa Fuminari, Ito Hiroto, Kayama Mami, Kashima Haruo
Format: Article
Language:English
Published: BMC 2011-07-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/11/118

Similar Items

Similar Items